Figure 2 | British Journal of Cancer

Figure 2

From: [18F]2-Fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil

Figure 2

Cellular [18F]2-fluoro-2-deoxy-D-glucose (18FDG) incorporation, per milligram cellular protein, after 48 (A) and 72 (B) h treatment with lethal dose 10 (LD10) (white) and LD50 (grey) doses of epirubicin, 5-FU or cisplatin expressed as a percentage of incorporation by untreated controls (E=epirubicin, C=cisplatin, F=5-fluorouracil).

Back to article page